NCT04743453 EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS. Status COMPLETED Phase PHASE4
NCT04724837 Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial) Status COMPLETED Phase PHASE2
NCT04707352 Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure . Status COMPLETED Phase PHASE3
NCT04707261 Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) Status RECRUITING Phase PHASE4
NCT04706637 A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin Status UNKNOWN Phase PHASE4
NCT04634500 The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. Status COMPLETED Phase PHASE3
NCT04595370 Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT04575675 Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy Status COMPLETED Phase PHASE4
NCT04570865 Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS® Status UNKNOWN Phase PHASE4
NCT04564742 Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack. Status COMPLETED Phase PHASE3
NCT04542291 Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition Status COMPLETED Phase PHASE1
NCT04534270 Efficacy and Safety of Dapagliflozin in Children With Proteinuria Status COMPLETED Phase PHASE4
NCT04475042 Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction Status UNKNOWN Phase PHASE2
NCT04451837 Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04393246 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms Status COMPLETED Phase PHASE2/PHASE3
NCT04385589 Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure Status COMPLETED Phase PHASE4
NCT04363697 Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) Status COMPLETED Phase PHASE4
NCT04304430 Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors Status COMPLETED Phase N/A